Company Filing History:
Years Active: 2025
Title: William H Tepp: Innovator in COVID-19 Vaccine Development
Introduction
William H Tepp is a notable inventor based in Stoughton, Wisconsin. He has made significant contributions to the field of vaccine development, particularly in the fight against COVID-19. His innovative approach has led to the creation of a unique vaccine formulation that targets the SARS-CoV-2 virus.
Latest Patents
William H Tepp holds a patent for a COVID-19 vaccine. The patent describes antigenic peptides comprising the SARS-CoV-2 spike protein receptor binding domain (CRBD) polypeptide or portions thereof, linked to a non-catalytic, non-toxic tetanus toxin variant, known as a modified tetanus toxin or 'MTT'. The patent also includes vaccine compositions comprising these elements and methods for making and using CRBD-MTT fusion proteins as immunogenic agents.
Career Highlights
Throughout his career, Tepp has worked with esteemed organizations such as the Medical College of Wisconsin and the Wisconsin Alumni Research Foundation. His work has been pivotal in advancing medical research and vaccine technology.
Collaborations
Tepp has collaborated with notable colleagues, including Joseph T Barbieri and Amanda Przedpelski. These partnerships have contributed to the success of his research and innovations.
Conclusion
William H Tepp's contributions to vaccine development, particularly in relation to COVID-19, highlight his role as an important figure in the field of medical innovation. His work continues to impact public health and safety.